These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35981468)

  • 1. A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation.
    Jones SK; Wolf BJ; Froeliger B; Wallace K; Carpenter MJ; Alberg AJ
    Drug Alcohol Depend; 2022 Oct; 239():109596. PubMed ID: 35981468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
    Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
    BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
    Bergen AW; Javitz HS; Krasnow R; Nishita D; Michel M; Conti DV; Liu J; Lee W; Edlund CK; Hall S; Kwok PY; Benowitz NL; Baker TB; Tyndale RF; Lerman C; Swan GE
    Pharmacogenet Genomics; 2013 Feb; 23(2):94-103. PubMed ID: 23249876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.
    Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Schatzberg AF; Murphy GM
    Am J Med Genet B Neuropsychiatr Genet; 2011 Apr; 156B(3):275-84. PubMed ID: 21268243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.
    Schuit E; Panagiotou OA; Munafò MR; Bennett DA; Bergen AW; David SP
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011823. PubMed ID: 28884473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.
    Tyndale RF; Zhu AZ; George TP; Cinciripini P; Hawk LW; Schnoll RA; Swan GE; Benowitz NL; Heitjan DF; Lerman C;
    PLoS One; 2015; 10(5):e0128109. PubMed ID: 26010901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
    Chen LS; Bloom AJ; Baker TB; Smith SS; Piper ME; Martinez M; Saccone N; Hatsukami D; Goate A; Bierut L
    Addiction; 2014 Jan; 109(1):128-137. PubMed ID: 24033696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the rs1051730-rs16969968 variant and smoking cessation treatment: a meta-analysis.
    Leung T; Bergen A; Munafò MR; De Ruyck K; Selby P; De Luca V
    Pharmacogenomics; 2015; 16(7):713-20. PubMed ID: 25950378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.
    Falcone M; Jepson C; Benowitz N; Bergen AW; Pinto A; Wileyto EP; Baldwin D; Tyndale RF; Lerman C; Ray R
    Nicotine Tob Res; 2011 Jun; 13(6):498-503. PubMed ID: 21385908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism.
    Wen L; Jiang K; Yuan W; Cui W; Li MD
    Mol Neurobiol; 2016 Jan; 53(1):472-484. PubMed ID: 25471942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
    Panagiotou OA; Schuit E; Munafò MR; Bennett DA; Bergen AW; David SP
    Nicotine Tob Res; 2019 Aug; 21(9):1289-1293. PubMed ID: 30690475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.
    Culverhouse RC; Chen LS; Saccone NL; Ma Y; Piper ME; Baker TB; Bierut LJ
    Nicotine Tob Res; 2020 Feb; 22(2):248-255. PubMed ID: 30882151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
    Pintarelli G; Galvan A; Pozzi P; Noci S; Pasetti G; Sala F; Pastorino U; Boffi R; Colombo F
    Sci Rep; 2017 Dec; 7(1):16730. PubMed ID: 29196725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    Cahill K; Stevens S; Perera R; Lancaster T
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of successful smoking cessation: convergent genome-wide association study results.
    Uhl GR; Liu QR; Drgon T; Johnson C; Walther D; Rose JE; David SP; Niaura R; Lerman C
    Arch Gen Psychiatry; 2008 Jun; 65(6):683-93. PubMed ID: 18519826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressants for smoking cessation.
    Hughes JR; Stead LF; Hartmann-Boyce J; Cahill K; Lancaster T
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD000031. PubMed ID: 24402784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHRNA5-A3-B4 and DRD2 Genes and Smoking Cessation Throughout Adulthood: A Longitudinal Study of Women.
    Jones SK; Alberg AJ; Wallace K; Froeliger B; Carpenter MJ; Wolf BJ
    Nicotine Tob Res; 2023 May; 25(6):1164-1173. PubMed ID: 36794842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits.
    Muderrisoglu A; Babaoglu E; Korkmaz ET; Kalkisim S; Karabulut E; Emri S; Babaoglu MO
    Front Genet; 2022; 13():812715. PubMed ID: 35222535
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes.
    Saccone NL; Saccone SF; Hinrichs AL; Stitzel JA; Duan W; Pergadia ML; Agrawal A; Breslau N; Grucza RA; Hatsukami D; Johnson EO; Madden PA; Swan GE; Wang JC; Goate AM; Rice JP; Bierut LJ
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jun; 150B(4):453-66. PubMed ID: 19259974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.